ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia
基于 ASXL1/TET2 基因型的风险分层优于 ASXL1 突变的影响,并且与慢性粒单核细胞白血病中的突变变异等位基因频率无关。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.285410
Csizmar, Clifford M; Gurney, Mark; Kanagal-Shamanna, Rashmi; Chien, Kelly; Hammond, Danielle; Lasho, Terra L; Finke, Christy M; Dean, Christopher; Natu, Anuya; Mangaonkar, Abhishek A; Al-Kali, Aref; Gangat, Naseema; Tefferi, Ayalew; Alkhateeb, Hassan; Garcia-Manero, Guillermo; Komrokji, Rami S; Ali, Najla A; Padron, Eric; Montalban-Bravo, Guillermo; Patnaik, Mrinal M